When It Comes To Diabetes, Will Marketers Break With Tradition?
When it comes to diabetes, will marketers break with tradition? When it comes to diabetes, will marketers break with tradition? The fiercely competitive diabetes drug market is in line for a dramatic overhaul, one that would place more emphasis than ever on the well-being of the consumer. As diabetes strengthens its grasp on America's health, what's needed most is messaging that targets those at risk for the complex disease and better tools for those already diagnosed. Many marketers believe diabetes patients have already started benefiting from the unprecedented volume of disease-awareness campaigns plucked straight from the clutches of pharma marketers' budgets. At the same time, others doubt pharma's ability to break from tradition. See also: Lexicon developing type 1 diabetes treatment with Sanofi Are drug manufacturers shying away from these efforts because they're worried the well of diabetes patients will dry up? Top executives have been vocal about their wish that marketers would recognize diabetes as a continually growing market. Contrary to diseases such as muscular dystrophy where virtually every patient is enrolled in a clinical trial the diabetes landscape is vast and Continue reading >>